Organic lithium salts
Medchemexpress LLC Lithium acetate dihy 500g
Lithium acetate dihydrate is a compound with a one-dimensional structure that has various applications in industries such as pharmaceuticals ceramics and research laboratories Lithium acetate dihydrate is often used as a source of lithium ions in chemical reactions and as a precursor in the synthesis of other lithium compounds[1]
Sigma Aldrich Fine Chemicals Biosciences Lithium acetate dihydrate1KG
Lithium acetate dihydrate is one of the commercially available forms of lithium acetate. Lithium acetate is a common salt with variety of applications such as product for efficient yeast transformation drug formulation and therapy lithium-6 CP/MAS standard solvent and catalyst. In addition it is also used as a buffer for gel electrophoresis of DNA and RNA additive or catalyst for textiles and polymer production and as a precursor material for batteries and ferromagnetic nanoparticles.
Cayman Chemical EthylR- 3-Hydroxybutyra 1g
A chiral starting material for the production of numerous biologically active compounds
Cayman Chemical EthylR- 3-Hydroxybutyra 5g
A chiral starting material for the production of numerous biologically active compounds
Boston Bioproducts Inc PEG 8000 (20%), Sodium Chloride (2.5 M) - 4x250ml
PEG 8000 (20%) Sodium Chloride (2 5 M) - 4x250ml (For Research Use and Further Manufacturing Only)
AdipoGen Bis(trifluoromethane)sulfonimide lithium salt
Bis(trifluoromethane)sulfonimide lithium salt, AdipoGen Life Sciences. Chemical. CAS: 90076-65-6. Formula: C2F6LiNO4S2. MW: 287.09. Synthetic Used in the preparation of electrolyte suitable for lithium batteries showing very high conductivity. Used in the preparation of a chiral imidazolium salt via anion metathesis of the corresponding triflate.
Cayman Chemical EthylR- 3-Hydroxybutyra 25g
A chiral starting material for the production of numerous biologically active compounds
Medchemexpress LLC Mevalonic acid lithium salt | 2618458-93-6 | 98.0% | 154.09 | 10 MG
Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. It is effective in inhibiting Simvastatin-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure.
- Precursor substance of the mevalonate pathway.
- Essential for cell growth and proliferation.
- Effective in inhibiting Simvastatin-induced decrease in C2C12 cell viability in vitro.
- Can be used in studies of myopathy and heart failure.
- High purity.
- Available in solid and solution forms.
- Supported by multiple publications citing its use.
Teknova 20 PEG 8000 with 2.5M Sodium
20% PEG 8000 with 2.5M Sodium Chloride. 50mL, Sterile. DNase and RNase Tested. 25 pack.
Medchemexpress LLC Lith-O-Asp | 881179-02-8 | MFCD31692386 | 98.0% | 491.66 g/mol | C28H45NO6 | 5 MG
Lith-O-Asp is a small-molecule sialyltransferase (ST) inhibitor reported to inhibit ST activity with IC50 values of 12-37 μM. It is provided as a purified research reagent in solid form for biochemical and cell-based studies; not for human therapeutic use.
- Inhibits sialyltransferase with IC50 12-37 μM.
- High purity (98.0%).
- Molecular formula C28H45NO6 and molecular weight 491.66 g/mol.
- Supplied as a solid in milligram quantities suitable for screening and assays.
- Intended for research use only; not for therapeutic applications.
- CAS number 881179-02-8 for unambiguous identification.
Medchemexpress LLC Lith-O-Asp | 881179-02-8 | 98.0% | 491.66 | 100 MG
Lith-O-Asp is a sialyltransferase (ST) inhibitor with IC50s of 12-37 μM. It inhibits the activities of ST3Gal I, ST3Gal III, and ST6GalI, decreasing the expression of cell surface α-2,3- and α-2,6-sialylated antigens.
- Inhibits sialyltransferase (ST) activities with IC50 values ranging from 12 to 37 μM.
- Decreases the activity of both α-2,3- and α-2,6-sialyltransferases.
- Inhibits the transfer of sialic acids to targeted glycoproteins.
- Shows no apparent growth inhibition effect toward different cancer cell lines at tested doses.
- Leads to fewer lung metastases in treated mice.
- Decreases average tumor nodules per mouse in vivo.